India markets open in 1 hour 49 minutes
  • BSE SENSEX

    52,950.63
    +363.79 (+0.69%)
     
  • Nifty 50

    15,885.15
    +122.10 (+0.77%)
     
  • Dow

    34,838.16
    -97.31 (-0.28%)
     
  • Nasdaq

    14,681.07
    +8.39 (+0.06%)
     
  • BTC-INR

    2,895,452.50
    -50,403.50 (-1.71%)
     
  • CMC Crypto 200

    950.40
    -10.49 (-1.09%)
     
  • Hang Seng

    26,059.59
    -176.21 (-0.67%)
     
  • Nikkei

    27,542.04
    -238.98 (-0.86%)
     
  • EUR/INR

    88.2832
    +0.0074 (+0.01%)
     
  • GBP/INR

    103.2752
    -0.0174 (-0.02%)
     
  • AED/INR

    20.1950
    -0.0040 (-0.02%)
     
  • INR/JPY

    1.4670
    +0.0007 (+0.05%)
     
  • SGD/INR

    54.9580
    -0.0150 (-0.03%)
     

Pune-based start-up develops mask that inactivates novel coronavirus

·2-min read

New Delhi, Jun 14 (PTI) A Pune-based start-up has integrated 3D printing and pharmaceuticals to develop a mask which inactivates viral particles that come in contact with it, the Department Science and Technology said on Monday.

Developed by Thincr Technologies India Private Limited, these masks are coated with anti-viral agents known otherwise as virucides.

The coating has been tested and shown to inactivate the SARS-CoV-2, the DST said, adding the material used in it is a Sodium Olefin Sulfonate-based mixture, a soap-forming agent.

In contact with enveloped viruses, it disrupts the outer membrane of the virus. The ingredients used are stable at room temperature and are widely used in cosmetics.

The DST said that as part of the fight against COVID-19, the virucidal mask initiative was among the earliest projects to have been selected for commercialisation by the Technology Development Board (TDB), a statutory body under the Department of Science and Technology.

Thincr Technologies India works in development of Fused Deposition Modeling (FDM) 3D-printers to discover new pharmaceutical formulations and drug-loaded filaments of different types.

'We sensed that use of face masks will become nearly universal as the most important tool to prevent infection. But we realised that most masks which were then available and within the reach of common people were homemade and of relatively low quality.

'It is this need for high-quality masks which led us to undertake a project to develop and commercialise cost-effective and more efficient virucidal coated masks, as a better approach to reduce the spread of infection,' said Shitalkumar Zambad, the Founder-Director of Thincr Technologies India.

Thincr Technologies India Pvt Ltd has applied for a patent for this product. Commercial scale manufacturing has also started, he added. PTI PR TIR TIR

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting